0001209191-15-067383.txt : 20150821
0001209191-15-067383.hdr.sgml : 20150821
20150821170821
ACCESSION NUMBER: 0001209191-15-067383
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150819
FILED AS OF DATE: 20150821
DATE AS OF CHANGE: 20150821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PHILLIPS BARCLAY A
CENTRAL INDEX KEY: 0001265801
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 151069420
MAIL ADDRESS:
STREET 1: C/O CANCER VAX CORP
STREET 2: 2110 RUTHERFORD ROAD
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-19
0
0001000694
NOVAVAX INC
NVAX
0001265801
PHILLIPS BARCLAY A
C/O NOVAVAX, INC.
20 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
0
1
0
0
SVP, Chief Financial Officer
Common Stock
2015-08-19
4
S
0
18656
13.1969
D
19152
D
Common Stock
2015-08-20
4
S
0
10000
12.8122
D
9152
D
The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.19 to $13.22, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.81 to $12.82, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ John A. Herrmann III, Attorney-in-Fact
2015-08-21